NEWS
Our Latest News
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
Private equity healthcare specialist ARCHIMED announces the sale of DIESSE to private equity firm Fremman Capital. The transaction caps a five-year partnership with DIESSE and marks the latter’s transformation into a leading clinical diagnostics innovator. The deal returns 4.6 times invested capital to shareholders.
Primo sponsors the Executive Master in Management specialized in Healthcare Business
December
9,
2016
En quête d’entreprises profitables
November
14,
2016
ARCHIMED buys four companies; HIS, Fytexia, Polyplus, and Micromed
September
20,
2016
ARCHIMED acquires Deallus Consulting
November
9,
2015
368